Gene · 2642
Papers2,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Survodutide for the treatment of obesity: Mechanistic rationale, clinical evidence, and remaining uncertainties. | Contemp Clin Trials | 2026 | 42822760 | PubTator, text mining | PubMed |
| Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes. | N Engl J Med | 2026 | 42820639 | PubTator, text mining | PubMed |
| Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-Analysis. | Diabetes Obes Metab | 2026 | 42811393 | PubTator, text mining | PubMed |
| Metabolic control by liver-kidney crosstalk and glucagon in health and disease. | Nat Rev Nephrol | 2026 | 42811087 | PubTator, text mining | PubMed |
| GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism. | Biochem Pharmacol | 2026 | 42777788 | PubTator, text mining | PubMed |
| [New Therapeutic Approaches for MASH: Mechanisms and Clinical Promise]. | Z Gastroenterol | 2026 | 42777699 | PubTator, text mining | PubMed |
| Approach to the patient with primary hyperglucagonemia. | J Clin Endocrinol Metab | 2026 | 42766419 | PubTator, text mining | PubMed |
| Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis. | Rapid Commun Mass Spectrom | 2026 | 42745421 | PubTator, text mining | PubMed |
| Structural basis for small-molecule agonism at GCGR and GIPR via a conserved intracellular allosteric site. | Acta Pharmacol Sin | 2026 | 42736455 | PubTator, text mining | PubMed |
| Cardiovascular effects of incretin receptor agonists: beyond glycemic control. | Can J Physiol Pharmacol | 2026 | 42721492 | PubTator, text mining | PubMed |
| Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis. | Cell Rep Med | 2026 | 42697203 | PubTator, text mining | PubMed |
| Online-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis. | Cureus | 2026 | 42669023 | PubTator, text mining | PubMed |
| Recent Advances in Diabetes Therapies in Asia. | Diabetes Care | 2026 | 42627354 | PubTator, text mining | PubMed |
| Cardiometabolic Effects of Dual GLP-1 and Glucagon Receptor Agonists: A Systematic Review and Meta-analysis of Randomized Controlled Trials. | Diabetes Care | 2026 | 42627353 | PubTator, text mining | PubMed |
| Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs. | World J Methodol | 2026 | 42626202 | PubTator, text mining | PubMed |
| Role of glucagon in metabolic diseases. | J Diabetes Investig | 2026 | 42593182 | PubTator, text mining | PubMed |
| Multi-Omics Identification of Vasculogenic Mimicry-Associated Molecular Subtypes in Hepatocellular Carcinoma for Prognostic Stratification and Therapeutic Response Prediction. | Cancers (Basel) | 2026 | 42588699 | PubTator, text mining | PubMed |
| Lower glucagon response and attenuated hepatic glucagon signaling in MASLD. | Diabetes Metab | 2026 | 42580550 | PubTator, text mining | PubMed |
| Pharmacologic management of metabolic and alcohol-associated liver disease. | Metab Target Organ Damage | 2026 | 42577825 | PubTator, text mining | PubMed |
| From indirect regulation to multi-layered metabolic control in MASLD: Multi-receptor agonism and microbiota-metabolite functional convergence. | Pharmacol Res | 2026 | 42570767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2642/papers